Jun 20, 2024 | Laboratory UTCBS
The Alnylam Pharmaceuticals 2024 “Interfering RNA & Rare Diseases” Prize has been awarded to Virginie Escriou, for her research entitled “Therapeutic strategies based on orally administered siRNA”. The prize was delivered at the Annual...
Jun 14, 2024 | Laboratory UTCBS, Research
On Friday June 7, the UTCBS students’ day took place at the Faculty of Pharmacy, organized by the laboratory’s PhD students. The day was an opportunity for students and post-docs to talk about their studies and training. During the event, we had the...
May 3, 2024 | Laboratory UTCBS, Research
The LHF Espoir and Artistes Sportifs de Coeur associations presented a cheque to the biotherapy team to support its research project, which aims to administer mRNA to restore the expression of the missing protein in genetic diseases such as Microvillous Inclusion...
Feb 22, 2024 | Laboratory UTCBS, Research
A disease is considered rare when it affects less than 1 in 2,000 people. There are around 7,000 such diseases, affecting 3 million people in France. But most of these diseases are still shrouded in secrecy: the cause of more than half of them is unknown, which...
Feb 9, 2024 | Laboratory UTCBS
A great first day at #HYBRID2024! This morning, after an introduction by Bruno Bonnel, General Secretary for #Investment, we had the privilege of exploring new generations of vectors for gene therapy, as well as genome-editing strategies using Crispr Cas9. The round...
